nLc4Cer (d18:1/18:0) is a glycolipid subtype, which can be used as a useful glycosphingolipid standard in the research of the mechanisms of cancer development and progression.
CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.